Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma.
Ann Oncol
; 19(8): 1500-1508, 2008 Aug.
Article
in En
| MEDLINE
| ID: mdl-18385200
Full text:
1
Database:
MEDLINE
Main subject:
Tetrahydrofolate Dehydrogenase
/
Bone Neoplasms
/
Osteosarcoma
/
Methotrexate
/
Genes, myc
Type of study:
Guideline
/
Risk_factors_studies
Limits:
Adult
/
Humans
Language:
En
Year:
2008
Type:
Article